Abstract
P-144 Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have